# The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome

> **NCT00926341** · PHASE4 · COMPLETED · sponsor: **Aligarh Muslim University** · enrollment: 110 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Pioglitazone
- **DRUG:** Telmisartan

## Key facts

- **NCT ID:** NCT00926341
- **Lead sponsor:** Aligarh Muslim University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2008-06
- **Final completion:** 2008-09
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2009-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00926341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00926341, "The Effects of Peroxisome Proliferators Activated Receptor-Gamma (PPAR-γ) Agonists on Certain Biochemical and Inflammatory Markers in Metabolic Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00926341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*